International Patent: METHOD OF PROPHYLAXIS TO PREVENT ATTACKS OF HEREDITARY ANGIOEDEMA IN PEDIATRIC PATIENTS

GENEVA, Aug. 14 -- BIOCRYST PHARMACEUTICALS, INC. filed a patent application (US2026/014692) for “METHOD OF PROPHYLAXIS TO PREVENT ATTACKS OF HEREDITARY ANGIOEDEMA IN PEDIATRIC PATIENTS”. With publication no. WO/2026/170177, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 9/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....